![](/img/cover-not-exists.png)
Oral versus intravenous palonosetron in Chinese cancer patients receiving moderately emetogenic chemotherapy: A nonâinferiority phase III trial
Cui, Jiuwei, Zhang, Qingyuan, Zhang, Hongyu, Spinelli, Tulla, Nicolas, Pierre, Li, WeiJournal:
European Journal of Cancer Care
DOI:
10.1111/ecc.13245
Date:
June, 2020
File:
PDF, 554 KB
2020